Clarity Pharmaceuticals Ltd (CLRPF)
OTCMKTS · Delayed Price · Currency is USD
2.120
0.00 (0.00%)
Sep 5, 2025, 9:30 AM EDT
Clarity Pharmaceuticals Market Cap
Clarity Pharmaceuticals has a market cap or net worth of $768.81 million as of September 8, 2025. Its market cap has decreased by -48.55% in one year.
Market Cap
768.81M
Enterprise Value
713.61M
Revenue
6.20M
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.12
Market Cap Chart
Since August 25, 2021, Clarity Pharmaceuticals's market cap has increased from 278.91M to 768.81M, an increase of 175.65%. That is a compound annual growth rate of 28.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 768.81M | -7.14% |
| Dec 31, 2024 | 827.89M | 143.75% |
| Dec 29, 2023 | 339.64M | 94.39% |
| Dec 30, 2022 | 174.72M | 26.78% |
| Dec 31, 2021 | 137.82M | -50.59% |
| Aug 25, 2021 | 278.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 825.37M |
| Elite Pharmaceuticals | 749.52M |
| Tian'an Technology Group | 705.53M |
| Glass House Brands | 600.85M |
| CytoDyn | 396.74M |
| Northwest Biotherapeutics | 376.41M |
| American Oncology Network | 353.52M |